-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Prostate Cancer - 4/28/2022
1:30:43
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Ovarian Cancer - 4/28/2022
1:32:29
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Non-Small Cell Lung Cancer - 4/28/2022
2:02:37
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Hepatobiliary Cancers - 4/28/2022
56:27
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Small Cell Lung Cancer - 4/29/2022
1:31:43
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Chronic Lymphocytic Leukemia - 4/29/2022
1:31:30
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Breast Cancer - 4/29/2022
1:59:59
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Acute Myeloid Leukemia and Myelodysplastic Syndromes - 4/29/2022
1:03:26
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Cervical and Endometrial Cancer - 4/30/2022
1:32:08
-
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation: Bladder Cancer - 4/30/2022
1:32:15
-
What I Tell My Patients: New Treatments and Clinical Trial Options - Gastroesophageal Cancers - 5/18/2022
1:02:35
- Next Page
